Navigation Links
Mindray Announces Second Quarter 2011 Financial Results
Date:8/8/2011

>

Business Outlook for Full Year 2011The company maintains its full year guidance and anticipates its full year 2011 net revenues to be more than 16% higher than its full year 2010 net revenues.

The company continues to project its full year 2011 non-GAAP net income to grow more than 10% over its non-GAAP net income for full year 2010. This guidance excludes the tax benefits related to the key software enterprise status ($8.6 million and $7.6 million recognized in the first quarter of 2010 and 2011 respectively) and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.

The company expects its capital expenditure for 2011 to remain in the range of $70 million to $80 million.

The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.

"We are maintaining our guidance at this time," commented Li Xiting, Mindray's president and co-chief executive officer. "Most of our key global markets continue to have favorable growth prospects. In China, we are excited to see increased patient traffic and spending on county level hospitals. Together with our strategic efforts in China, we are optimistic that our China business is back on track. Emerging markets continue to exhibit strong growth momentum, although we are closely monitoring the political situation in the Middle East and Africa. Developed markets as a whole also keep growing steadily. In the second quarter, we once again demonstrated our focus on profitability and cash generation. In the coming quarters, our commitment to technology and product innovation, coupled with potential additional acquisitions, will fuel our future growth and expansion."

Conference Call InformationMindray's management will hold an earnings conference call at 8:00 AM on August 9, 2011 U.S. Eastern Time (8:00 PM on August 9, 2011 Beijing/Hong Kong Time)
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Mindray to Report Second Quarter 2011 Financial Results on August 8, 2011
2. Mindray Medical Provides Mid-Year Update on Product Development
3. Mindray Medical to Acquire a Controlling Stake in Suzhou Hyssen Electronics
4. Mindray Medical Receives the 2011 Medical Device Excellence Award for its V Series Patient Monitoring System
5. Mindray Appoints Ms. Fannie Lin Fan as General Counsel
6. Mindray Announces First Quarter 2011 Financial Results
7. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
8. Mindray to Report First Quarter 2011 Financial Results on May 9, 2011
9. Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair
10. Mindray Appoints Mr. Jie Liu as Chief Financial Officer
11. Mindray Medical to Present at the 14th Annual Credit Suisse Asian Investment Conference on March 21-25
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
(Date:7/11/2014)... , July 11, 2014  Rock Creek Pharmaceuticals, Inc. ... today announced that the Food and Drug Administration ("FDA"), ... comments on RCP,s Investigational New Drug ("IND") application before ... in the US. Dr. Chris Chapman ... and comments on our IND. When we receive the ...
(Date:7/11/2014)... -- Kindred Hospital Houston Northwest, with Wound Care Specialists, ... new outpatient wound healing center.  The wound healing ... hard to heal wounds. Chronic wounds include diabetic ... leg wounds related to blood flow issues, post-surgical ... wounds which are complex and demonstrate delayed healing. ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... April 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... present data regarding its SCORPION(TM) multispecific therapeutic technology ... Association of Cancer Research (AACR) in Denver, April ... present data demonstrating the selectivity and high potency ...
... April 16 Simbionix, the world,s leading,developer of medical ... LLC for distribution of Simbionix,s simulators and related,products. , ... in Russia, Ukraine and CIS countries and,is one of ... Johnson & Johnson LLC will have exclusive ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2
(Date:7/13/2014)... research in Nature Genetics identifies a ... that causes eosinophillic esophagitis (EoE), opening up potential ... food allergy. , EoE is a chronic ... triggered by allergic hypersensitivity to certain foods and ... cells called eosinophils (part of the body,s immune ...
(Date:7/13/2014)... Chromatography system is a physical method of separation ... samples such as air and water. Chromatography systems ... namely mobile phase and stationary phase. The components ... phase, followed by the differential rate of migration ... mixture. Chromatography system plays an important role in ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Victorian Hotel ... by promoting the rental of bikes for its "Cycle ... downtown Victorian Hotel to tour the area using a ... tax. Bicycle enthusiasts love to call Vancouver home, as ... for cycle travel and picturesque journeys through the countryside. ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Micro irrigation ... ensure proper water dispersal as wells as to maintain ... agriculture is projected to become a dominant revenue generator ... sophisticated methods to reduce resource costs has led to ... and plantations, and has further caused massive demand for ...
(Date:7/13/2014)... 13, 2014 Advanced boilers are ... least amount of fossil fuels, produce high-capacity power, ... to increased global warming and climate change concerns, ... reduce harmful gas emissions and pollutants coming from ... in the global advance boilers market., The global ...
Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 3Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3
... MATEO, Calif., Feb. 28 NeurogesX, Inc.,(Nasdaq: ... and,commercializing novel pain management therapies, announced today that,Anthony ... to a,panel focused on pain management at Susquehanna ... Conference. Mr. DiTonno,is scheduled to present on Tuesday, ...
... latest technologies and ... medical advancements, AUSTIN, Texas, ... hospital, officially opened the expansion of its,heart hospital today with the ... rated as the number one overall,cardiac program in the State of ...
... diagnose severity of bipolar illness , , THURSDAY, Feb. 28 ... mood disorders have been identified by Indiana University School ... the way bipolar illness is diagnosed and treated. , ... found varying levels of the biomarkers in participants with ...
... (TSX: MDS; NYSE:,MDZ), a leading provider of products ... that the Company will report first quarter,results for ... will also host an analyst conference call with ... Douglas Prince,Executive Vice-President Finance and Chief Financial Officer, ...
... to $977.3mm for Full Year; Up 27% to $268.0mm for ... Fourth Quarter, - Adjusted EPS (incl. Stock Compensation) Up ... for Fourth Quarter (GAAP EPS ... up 62% to $0.47), - Continuing New Win Momentum and Pipeline Strengthening Across Segments, - ...
... 28 Cardiva Medical, Inc., a,privately held medical ... announces that it will present the highlights of ... 9:20am at the Medtech,Insight/Windhover Information,s "Investment In Innovation ... at The,Venetian in Las Vegas, NV., The ...
Cached Medicine News:Health News:NeurogesX to Present at Susquehanna Financial Group's 2nd Annual SIGnificant Options in Healthcare Conference 2Health News:NeurogesX to Present at Susquehanna Financial Group's 2nd Annual SIGnificant Options in Healthcare Conference 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 2Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 3Health News:Heart Hospital of Austin's Expansion Increases Patient Capacity by 30 Percent 4Health News:Biomarkers for Mood May Alter Psychiatric Treatments 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 3Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 4Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 5Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 6Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 7Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 8Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 9Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 10Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 11Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 12Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 13Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 14Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 15Health News:Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the 'Investment in Innovation (In3) West' Conference on February 29, 2008 in Las Vegas, NV 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: